Evidence map›Paper›PMID 41188574›Full record

ArticleNature chemistry2026

Non-ribosomal peptide cyclase-directed chemoenzymatic synthesis of lariat lipopeptides.

Masakazu Kobayashi, Kenichi Matsuda, Yuito Yamada, Rintaro Ichihara, Naho Onozawa, Hanako Fukano, Yoshihiko Hoshino, Aki Hirabayashi, Masato Suzuki, Akira Katsuyama and 2 more

Abstract read
In one paragraph

Article in Nature chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Masakazu Kobayashi *Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Kenichi Matsuda *Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan. kematsuda@pharm.hokudai.ac.jp.ORCID 0000-0002-9269-688X
Yuito YamadaFaculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Rintaro IchiharaFaculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Naho OnozawaFaculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Hanako FukanoDepartment of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Yoshihiko HoshinoDepartment of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan.ORCID 0000-0002-3132-0715
Aki HirabayashiAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Masato SuzukiAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Akira KatsuyamaFaculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.ORCID 0000-0002-4062-5561
Satoshi IchikawaFaculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.ORCID 0000-0001-5345-5007
Toshiyuki WakimotoFaculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan. wakimoto@pharm.hokudai.ac.jp.ORCID 0000-0003-2917-1797

Funding

Japan Agency for Medical Research and Development (AMED) JP25ak0101256Japan Agency for Medical Research and Development (AMED) JP25ama121039Japan Agency for Medical Research and Development (AMED) JP25gm1610007MEXT | Japan Science and Technology Agency (JST) ACT-X JPMJAX201FMEXT | Japan Science and Technology Agency (JST) A-STEP JPMJTR24U6MEXT | Japan Science and Technology Agency (JST) FOREST JPMJFR233UMEXT | Japan Society for the Promotion of Science (JSPS) JP21H02635MEXT | Japan Society for the Promotion of Science (JSPS) JP22H05128MEXT | Japan Society for the Promotion of Science (JSPS) JP22K15302MEXT | Japan Society for the Promotion of Science (JSPS) JP22KJ0097MEXT | Japan Society for the Promotion of Science (JSPS) JP23K17410MEXT | Japan Society for the Promotion of Science (JSPS) JP24K01659MEXT | Japan Society for the Promotion of Science (JSPS) JP25H00907
6 · The paper itself

Abstract

Lariat-shaped lipopeptides are important antimicrobial agents; however, their complex structures pose synthetic challenges that hamper efficient structural diversification. Here we report a new chemoenzymatic approach that facilitates access to lariat-shaped macrocycles. Unprotected, branched peptides bearing multiple nucleophiles, including a native amino terminus and a pseudo-amino terminus, were site-selectively cyclized using versatile non-ribosomal peptide cyclases, generating an array of lariat peptides with diverse sequences and ring sizes. The generality of this strategy was demonstrated using two penicillin-binding protein-type thioesterases, SurE and WolJ, as well as one type-I thioesterase, TycC thioesterase. Furthermore, the remaining nucleophile, which was not involved in the cyclization process, was exploited as a reactive handle for subsequent diversification via a site-selective acylation reaction (that is, Ser/Thr ligation). The tandem cyclization-acylation strategy enabled the one-pot, modular synthesis of lariat-shaped lipopeptides equipped with various acyl groups. Biological screening revealed that the site-selective acylation endowed the macrocyclic scaffolds with antimycobacterial activity and led to the identification of lipopeptides that inhibit 50% of growth at concentrations of 8-16 µg ml

Indexed as

Anti-Bacterial AgentsLipopeptidesPeptide SynthasesAcylationCyclizationAnti-Bacterial AgentsLipopeptidesnon-ribosomal peptide synthasePeptide Synthases

Identifiers

PMID41188574
PMCPMC12768971

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.